Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fromm

Showing results (221-230 of 233) with videos related to

Pageof 24
Sort By:
Clinical Pharmacology and Therapeutics|September 25, 2009
Genetic influences on the pharmacokinetics of orally and intravenously administered digoxin as exhibited by monozygotic twinsA L Birkenfeld, J Jordan, U Hofmann, et al.
Pharmacological Research|September 29, 2023
Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validationAnne T Nies, Jörg König, Patrick Leuthold, et al.
Gastroenterology|January 4, 2003
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitisMatthias Schwab, Elke Schaeffeler, Claudia Marx, et al.
Clinical Pharmacokinetics|June 7, 2020
Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and CimetidineSabrina T Wiebe, Thomas Giessmann, Kathrin Hohl, et al.
Clinical Pharmacokinetics|November 22, 2007
Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studiesSonja Eberl, Bertold Renner, Antje Neubert, et al.
The Pharmacogenomics Journal|April 4, 2007
Variability in human hepatic MRP4 expression: influence of cholestasis and genotypeU Gradhand, T Lang, E Schaeffeler, et al.
Human Mutation|February 27, 2008
6-mercaptopurine and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) transport altered by two missense mutations in the drug transporter gene ABCC4Daniel Janke, Sherif Mehralivand, Dennis Strand, et al.
Signal Transduction and Targeted Therapy|March 21, 2025
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugsNiklas Gremke, Isabelle Besong, Alina Stroh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2021
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer AgentsPauline Dürr, Katja Schlichtig, Carolin Kelz, et al.
Gut|January 4, 2024
ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivoAnja Schulz-Kuhnt, Katharina Rühle, Asal Javidmehr, et al.
Pageof 24

Showing results (221-230 of 233) with videos related to

Sort By:
Pageof 24
Clinical Pharmacology and Therapeutics|September 25, 2009
Genetic influences on the pharmacokinetics of orally and intravenously administered digoxin as exhibited by monozygotic twinsA L Birkenfeld, J Jordan, U Hofmann, et al.
Pharmacological Research|September 29, 2023
Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validationAnne T Nies, Jörg König, Patrick Leuthold, et al.
Gastroenterology|January 4, 2003
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitisMatthias Schwab, Elke Schaeffeler, Claudia Marx, et al.
Clinical Pharmacokinetics|June 7, 2020
Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and CimetidineSabrina T Wiebe, Thomas Giessmann, Kathrin Hohl, et al.
Clinical Pharmacokinetics|November 22, 2007
Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studiesSonja Eberl, Bertold Renner, Antje Neubert, et al.
The Pharmacogenomics Journal|April 4, 2007
Variability in human hepatic MRP4 expression: influence of cholestasis and genotypeU Gradhand, T Lang, E Schaeffeler, et al.
Human Mutation|February 27, 2008
6-mercaptopurine and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) transport altered by two missense mutations in the drug transporter gene ABCC4Daniel Janke, Sherif Mehralivand, Dennis Strand, et al.
Signal Transduction and Targeted Therapy|March 21, 2025
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugsNiklas Gremke, Isabelle Besong, Alina Stroh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2021
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer AgentsPauline Dürr, Katja Schlichtig, Carolin Kelz, et al.
Gut|January 4, 2024
ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivoAnja Schulz-Kuhnt, Katharina Rühle, Asal Javidmehr, et al.
Pageof 24